FDA — authorised 19 February 1948
- Application: NDA005914
- Marketing authorisation holder: NOVARTIS
- Local brand name: PBZ
- Indication: ELIXIR — ORAL
- Status: approved
🇺🇸 Pyribenzamin in United States
FDA authorised Pyribenzamin on 19 February 1948
Marketing authorisations
FDA
- Status: approved
Pyribenzamin in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Infectious Disease approved in United States
Frequently asked questions
Is Pyribenzamin approved in United States?
Yes. FDA authorised it on 19 February 1948; FDA has authorised it.
Who is the marketing authorisation holder for Pyribenzamin in United States?
NOVARTIS holds the US marketing authorisation.